Advertisement

Polysomnographic Features of Medical and Psychiatric Disorders and Their Treatments

  • David T. Plante
    Affiliations
    Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Search for articles by this author
  • John W. Winkelman
    Correspondence
    Corresponding author. Sleep Health Centers, 1505 Commonwealth Avenue, Brighton, MA 02459.
    Affiliations
    Department of Medicine, Divisions of Sleep Medicine and Psychiatry, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA

    Sleep Health Center®, Affiliated with Brigham & Women's Hospital, 1505 Commonwealth Avenue, Brighton, MA 02459, USA
    Search for articles by this author
      Psychiatric, neurologic, and medical illnesses, and their pharmacologic treatments affect the polysomnographic manifestations of sleep. Many patients undergoing sleep studies have multiple medical problems and often are taking many medications. Therefore, it is crucial that those interpreting sleep studies have an understanding of these effects. In this way, all the potential contributors to the polysomnographic findings can be addressed adequately. This article serves as a primer on changes in polysomnography (PSG) caused by commonly encountered disease states and their pharmacologic treatments.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders, fourth edition, text revision.
        American Psychiatric Association, Washington2000
        • Benca R.M.
        • Obermeyer W.H.
        • Thisted R.A.
        • et al.
        Sleep and psychiatric disorders. A meta-analysis.
        Arch Gen Psychiatry. 1992; 49 ([discussion: 669–70]): 651-668
        • Peterson M.J.
        • Benca R.M.
        Sleep in mood disorders.
        Sleep Med Clin. 2008; 3: 231-249
        • Coble P.A.
        • Kupfer D.J.
        • Shaw D.H.
        Distribution of REM latency in depression.
        Biol Psychiatry. 1981; 16: 453-466
        • Kupfer D.J.
        • Reynolds III, C.F.
        • Grochocinski V.J.
        • et al.
        Aspects of short REM latency in affective states: a revisit.
        Psychiatry Res. 1986; 17: 49-59
        • Kupfer D.J.
        • Reynolds III, C.F.
        • Ulrich R.F.
        • et al.
        Comparison of automated REM and slow-wave sleep analysis in young and middle-aged depressed subjects.
        Biol Psychiatry. 1986; 21: 189-200
        • Kupfer D.J.
        • Foster F.G.
        Interval between onset of sleep and rapid eye movement sleep as an indicator of depression.
        Lancet. 1972; 2: 684-686
        • Riemann D.
        • Voderholzer U.
        • Berger M.
        Sleep and sleep–wake manipulations in bipolar depression.
        Neuropsychobiology. 2002; 45: 7-12
        • Hudson J.I.
        • Lipinski J.F.
        • Frankenburg F.R.
        • et al.
        Electroencephalographic sleep in mania.
        Arch Gen Psychiatry. 1988; 45: 267-273
        • Hudson J.I.
        • Lipinski J.F.
        • Keck Jr., P.E.
        • et al.
        Polysomnographic characteristics of young manic patients. comparison with unipolar depressed patients and normal control subjects.
        Arch Gen Psychiatry. 1992; 49: 378-383
        • Gursky J.T.
        • Krahn L.E.
        The effects of antidepressants on sleep: a review.
        Harv Rev Psychiatry. 2000; 8: 298-306
        • Winkelman J.W.
        • James L.
        Serotonergic antidepressants are associated with REM sleep without atonia.
        Sleep. 2004; 27: 317-321
        • Yang C.
        • White D.P.
        • Winkelman J.W.
        Antidepressants and periodic leg movements of sleep.
        Biol Psychiatry. 2005; 58: 510-514
        • Ebrahim I.O.
        • Peacock K.W.
        REM sleep behavior disorder–psychiatric presentations: a case series from the United Kingdom.
        J Clin Sleep Med. 2005; 1: 43-47
        • Schenck C.H.
        • Mahowald M.W.
        • Kim S.W.
        • et al.
        Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive–compulsive disorder.
        Sleep. 1992; 15: 226-235
        • Wiegand M.
        • Berger M.
        • Zulley J.
        • et al.
        The effect of trimipramine on sleep in patients with major depressive disorder.
        Pharmacopsychiatry. 1986; 19: 198-199
        • Yang C.K.
        • Winkelman J.W.
        Antidepressant and antipsychotic drugs and sleep.
        in: Kilduff T.S. Armitage R. Marcus C.L. SRS basics of sleep guide. 1st edition. Sleep Research Society, Westchester (IL)2005: 167-173
        • Ott G.E.
        • Rao U.
        • Nuccio I.
        • et al.
        Effect of bupropion-SR on REM sleep: Relationship to antidepressant response.
        Psychopharmacology (Berl). 2002; 165: 29-36
        • Ott G.E.
        • Rao U.
        • Lin K.M.
        • et al.
        Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response.
        Int J Neuropsychopharmacol. 2004; 7: 275-281
        • Nofzinger E.A.
        • Reynolds III, C.F.
        • Thase M.E.
        • et al.
        REM sleep enhancement by bupropion in depressed men.
        Am J Psychiatry. 1995; 152: 274-276
        • Nofzinger E.A.
        • Fasiczka A.
        • Berman S.
        • et al.
        Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder.
        J Clin Psychiatry. 2000; 61: 858-862
        • Aslan S.
        • Isik E.
        • Cosar B.
        The effects of mirtazapine on sleep: a placebo-controlled, double-blind study in young healthy volunteers.
        Sleep. 2002; 25: 677-679
        • Onofrj M.
        • Luciano A.L.
        • Thomas A.
        • et al.
        Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.
        Neurology. 2003; 60: 113-115
        • Yamadera H.
        • Nakamura S.
        • Suzuki H.
        • et al.
        Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects.
        Psychiatry Clin Neurosci. 1998; 52: 439-443
        • Yamadera H.
        • Suzuki H.
        • Nakamura S.
        • et al.
        Effects of trazodone on polysomnography, blood concentration and core body temperature in healthy volunteers.
        Psychiatry Clin Neurosci. 1999; 53: 189-191
        • Vogal G.
        • Cohen J.
        • Mullis D.
        • et al.
        Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep?.
        Sleep. 1998; 21: 70-77
        • Sharpley A.L.
        • Walsh A.E.
        • Cowen P.J.
        Nefazodone—a novel antidepressant—may increase REM sleep.
        Biol Psychiatry. 1992; 31: 1070-1073
        • Sharpley A.L.
        • Williamson D.J.
        • Attenburrow M.E.
        • et al.
        The effects of paroxetine and nefazodone on sleep: a placebo-controlled trial.
        Psychopharmacology (Berl). 1996; 126: 50-54
        • Ware J.C.
        • Rose F.V.
        • McBrayer R.H.
        The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.
        Sleep. 1994; 17: 544-550
        • Sachs G.S.
        • Nierenberg A.A.
        • Calabrese J.R.
        • et al.
        Effectiveness of adjunctive antidepressant treatment for bipolar depression.
        N Engl J Med. 2007; 356: 1711-1722
        • Friston K.J.
        • Sharpley A.L.
        • Solomon R.A.
        • et al.
        Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?.
        Psychopharmacology (Berl). 1989; 98: 139-140
        • Saletu-Zyhlarz G.
        • Saletu B.
        • Anderer P.
        • et al.
        Nonorganic insomnia in generalized anxiety disorder. Controlled studies on sleep, awakening, and daytime vigilance utilizing polysomnography and EEG mapping.
        Neuropsychobiology. 1997; 36: 117-129
        • Arriaga F.
        • Paiva T.
        Clinical and EEG sleep changes in primary dysthymia and generalized anxiety: a comparison with normal controls.
        Neuropsychobiology. 1990; 24: 109-114
        • Papadimitriou G.N.
        • Kerkhofs M.
        • Kempenaers C.
        • et al.
        EEG sleep studies in patients with generalized anxiety disorder.
        Psychiatry Res. 1988; 26: 183-190
        • Mellman T.A.
        Sleep and anxiety disorders.
        Sleep Med Clin. 2008; 3: 261-268
        • Lavie P.
        Sleep disturbances in the wake of traumatic events.
        N Engl J Med. 2001; 345: 1825-1832
        • Mellman T.A.
        • Nolan B.
        • Hebding J.
        • et al.
        A polysomnographic comparison of veterans with combat-related PTSD, depressed men, and nonill controls.
        Sleep. 1997; 20: 46-51
        • Ross R.J.
        • Ball W.A.
        • Dinges D.F.
        • et al.
        Motor dysfunction during sleep in posttraumatic stress disorder.
        Sleep. 1994; 17: 723-732
        • Ross R.J.
        • Ball W.A.
        • Dinges D.F.
        • et al.
        Rapid eye movement sleep disturbance in post-traumatic stress disorder.
        Biol Psychiatry. 1994; 35: 195-202
        • Breslau N.
        • Roth T.
        • Burduvali E.
        • et al.
        Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study.
        Arch Gen Psychiatry. 2004; 61: 508-516
        • Brown T.M.
        • Black B.
        • Uhde T.W.
        The sleep architecture of social phobia.
        Biol Psychiatry. 1994; 35: 420-421
        • Robinson D.
        • Walsleben J.
        • Pollack S.
        • et al.
        Nocturnal polysomnography in obsessive–compulsive disorder.
        Psychiatry Res. 1998; 80: 257-263
        • Hohagen F.
        • Lis S.
        • Krieger S.
        • et al.
        Sleep EEG of patients with obsessive-compulsive disorder.
        Eur Arch Psychiatry Clin Neurosci. 1994; 243: 273-278
        • Kluge M.
        • Schussler P.
        • Dresler M.
        • et al.
        Sleep onset REM periods in obsessive compulsive disorder.
        Psychiatry Res. 2007; 152: 29-35
        • Lancel M.
        Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists.
        Sleep. 1999; 22: 33-42
        • Rao U.
        • Lutchmansingh P.
        • Poland R.E.
        Contribution of development to buspirone effects on REM sleep: a preliminary report.
        Neuropsychopharmacology. 2000; 22: 440-446
        • Seidel W.F.
        • Cohen S.A.
        • Bliwise N.G.
        • et al.
        Buspirone: an anxiolytic without sedative effect.
        Psychopharmacology (Berl). 1985; 87: 371-373
        • Benson K.L.
        Sleep in schizophrenia.
        Sleep Medicine Clinics. 2008; 3: 251-260
        • Chouinard S.
        • Poulin J.
        • Stip E.
        • et al.
        Sleep in untreated patients with schizophrenia: a meta-analysis.
        Schizophr Bull. 2004; 30: 957-967
        • Gimenez S.
        • Clos S.
        • Romero S.
        • et al.
        Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.
        Psychopharmacology (Berl). 2007; 190: 507-516
        • Cohrs S.
        Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics.
        CNS Drugs. 2008; 22: 939-962
        • Wetter T.C.
        • Lauer C.J.
        • Gillich G.
        • et al.
        The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
        J Psychiatr Res. 1996; 30: 411-419
        • Hinze-Selch D.
        • Mullington J.
        • Orth A.
        • et al.
        Effects of clozapine on sleep: a longitudinal study.
        Biol Psychiatry. 1997; 42: 260-266
        • Sharpley A.L.
        • Bhagwagar Z.
        • Hafizi S.
        • et al.
        Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.
        J Clin Psychiatry. 2003; 64: 192-196
        • Yamashita H.
        • Morinobu S.
        • Yamawaki S.
        • et al.
        Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol.
        Psychiatry Res. 2002; 109: 137-142
        • Sharpley A.L.
        • Vassallo C.M.
        • Cowen P.J.
        Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
        Biol Psychiatry. 2000; 47: 468-470
        • Cohrs S.
        • Rodenbeck A.
        • Guan Z.
        • et al.
        Sleep-promoting properties of quetiapine in healthy subjects.
        Psychopharmacology (Berl). 2004; 174: 421-429
        • Cohrs S.
        • Meier A.
        • Neumann A.C.
        • et al.
        Improved sleep continuity and increased slow-wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.
        J Clin Psychiatry. 2005; 66: 989-996
        • Malow B.A.
        Sleep and epilepsy.
        Neurol Clin. 2005; 23: 1127-1147
        • Sammaritano M.
        • Sherwin A.
        Effect of anticonvulsants on sleep.
        Neurology. 2000; 54: S16-S24
        • Bazil C.W.
        Effects of antiepileptic drugs on sleep structure: are all drugs equal?.
        CNS Drugs. 2003; 17: 719-728
        • Foldvary-Schaefer N.
        Sleep complaints and epilepsy: the role of seizures, antiepileptic drugs, and sleep disorders.
        J Clin Neurophysiol. 2002; 19: 514-521
        • Karacan I.
        • Orr W.
        • Roth T.
        • et al.
        Dose-related effects of phenobarbitone on human sleep–waking patterns.
        Br J Clin Pharmacol. 1981; 12: 303-313
        • Roder-Wanner U.U.
        • Noachtar S.
        • Wolf P.
        Response of polygraphic sleep to phenytoin treatment for epilepsy. A longitudinal study of immediate, short- and long-term effects.
        Acta Neurol Scand. 1987; 76: 157-167
        • Legros B.
        • Bazil C.W.
        Effects of antiepileptic drugs on sleep architecture: a pilot study.
        Sleep Med. 2003; 4: 51-55
        • Yang J.D.
        • Elphick M.
        • Sharpley A.L.
        • et al.
        Effects of carbamazepine on sleep in healthy volunteers.
        Biol Psychiatry. 1989; 26: 324-328
        • Gann H.
        • Riemann D.
        • Hohagen F.
        • et al.
        The influence of carbamazepine on sleep-EEG and the clonidine test in healthy subjects: results of a preliminary study.
        Biol Psychiatry. 1994; 35: 893-896
        • Ehrenberg B.L.
        • Eisensehr I.
        • Corbett K.E.
        • et al.
        Valproate for sleep consolidation in periodic limb movement disorder.
        J Clin Psychopharmacol. 2000; 20: 574-578
        • Rao M.L.
        • Clarenbach P.
        • Vahlensieck M.
        • et al.
        Gabapentin augments whole blood serotonin in healthy young men.
        J Neural Transm. 1988; 73: 129-134
        • Foldvary-Schaefer N.
        • De Leon Sanchez I.
        • Karafa M.
        • et al.
        Gabapentin increases slow-wave sleep in normal adults.
        Epilepsia. 2002; 43: 1493-1497
        • Foldvary N.
        • Perry M.
        • Lee J.
        • et al.
        The effects of lamotrigine on sleep in patients with epilepsy.
        Epilepsia. 2001; 42: 1569-1573
        • Hindmarch I.
        • Dawson J.
        • Stanley N.
        A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.
        Sleep. 2005; 28: 187-193
        • Bell C.
        • Vanderlinden H.
        • Hiersemenzel R.
        • et al.
        The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy.
        J Sleep Res. 2002; 11: 255-263
        • Bazil C.W.
        • Battista J.
        • Basner R.C.
        Effects of levetiracetam on sleep in normal volunteers.
        Epilepsy Behav. 2005; 7: 539-542
        • Cicolin A.
        • Magliola U.
        • Giordano A.
        • et al.
        Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers.
        Epilepsia. 2006; 47: 82-85
        • Mathias S.
        • Wetter T.C.
        • Steiger A.
        • et al.
        The GABA uptake inhibitor tiagabine promotes slow-wave sleep in normal elderly subjects.
        Neurobiol Aging. 2001; 22: 247-253
        • Walsh J.K.
        • Zammit G.
        • Schweitzer P.K.
        • et al.
        Tiagabine enhances slow-wave sleep and sleep maintenance in primary insomnia.
        Sleep Med. 2006; 7: 155-161
        • Roth T.
        • Wright Jr., K.P.
        • Walsh J.
        Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.
        Sleep. 2006; 29: 335-341
        • Kales A.
        • Ansel R.D.
        • Markham C.H.
        • et al.
        Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration.
        Clin Pharmacol Ther. 1971; 12: 397-406
        • Bergonzi P.
        • Chiurulla C.
        • Gambi D.
        • et al.
        L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
        Acta Neurol Belg. 1975; 75: 5-10
        • Neil J.F.
        • Holzer B.C.
        • Spiker D.G.
        • et al.
        EEG sleep alterations in olivopontocerebellar degeneration.
        Neurology. 1980; 30: 660-662
        • Manni R.
        • Morini R.
        • Martignoni E.
        • et al.
        Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients.
        J Neurol. 1993; 240: 249-250
        • Wetter T.C.
        • Collado-Seidel V.
        • Pollmacher T.
        • et al.
        Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy.
        Sleep. 2000; 23: 361-367
        • Bliwise D.L.
        • Willians M.L.
        • Irbe D.
        • et al.
        Inter-rater reliability for identification of REM sleep in parkinson's disease.
        Sleep. 2000; 23: 671-676
        • Wyatt R.J.
        • Chase T.N.
        • Scott J.
        • et al.
        Effect of L-dopa on the sleep of man.
        Nature. 1970; 228: 999-1001
        • Gillin J.C.
        • Post R.M.
        • Wyatt R.J.
        • et al.
        REM inhibitory effect of L-DOPA infusion during human sleep.
        Electroencephalogr Clin Neurophysiol. 1973; 35: 181-186
        • Gagnon J.F.
        • Postuma R.B.
        • Mazza S.
        • et al.
        Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.
        Lancet Neurol. 2006; 5: 424-432
        • Comella C.L.
        Sleep disorders in Parkinson's disease: an overview.
        Mov Disord. 2007; 22: S367-S373
        • Ferreira J.J.
        • Galitzky M.
        • Montastruc J.L.
        • et al.
        Sleep attacks and Parkinson's disease treatment.
        Lancet. 2000; 355: 1333-1334
        • Ferreira J.J.
        • Galitzky M.
        • Thalamas C.
        • et al.
        Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers.
        Neurology. 2002; 58: 460-462
        • Saletu M.
        • Anderer P.
        • Saletu-Zyhlarz G.
        • et al.
        Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
        Eur Arch Psychiatry Clin Neurosci. 2002; 252: 185-194
        • Allen R.
        • Becker P.M.
        • Bogan R.
        • et al.
        Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
        Sleep. 2004; 27: 907-914
        • Prinz P.N.
        • Peskind E.R.
        • Vitaliano P.P.
        • et al.
        Changes in the sleep and waking EEGs of nondemented and demented elderly subjects.
        J Am Geriatr Soc. 1982; 30: 86-93
        • Prinz P.N.
        • Vitaliano P.P.
        • Vitiello M.V.
        • et al.
        Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type.
        Neurobiol Aging. 1982; 3: 361-370
        • Petit D.
        • Gagnon J.F.
        • Fantini M.L.
        • et al.
        Sleep and quantitative EEG in neurodegenerative disorders.
        J Psychosom Res. 2004; 56: 487-496
        • Kanbayashi T.
        • Sugiyama T.
        • Aizawa R.
        • et al.
        Effects of donepezil (aricept) on the rapid eye movement sleep of normal subjects.
        Psychiatry Clin Neurosci. 2002; 56: 307-308
        • Schredl M.
        • Weber B.
        • Braus D.
        • et al.
        The effect of rivastigmine on sleep in elderly healthy subjects.
        Exp Gerontol. 2000; 35: 243-249
        • Mizuno S.
        • Kameda A.
        • Inagaki T.
        • et al.
        Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
        Psychiatry Clin Neurosci. 2004; 58: 660-665
        • Cooke J.R.
        • Loredo J.S.
        • Liu L.
        • et al.
        Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
        Drugs Aging. 2006; 23: 503-511
        • Aldrich M.S.
        • Foster N.L.
        • White R.F.
        • et al.
        Sleep abnormalities in progressive supranuclear palsy.
        Ann Neurol. 1989; 25: 577-581
        • Montplaisir J.
        • Petit D.
        • Decary A.
        • et al.
        Sleep and quantitative EEG in patients with progressive supranuclear palsy.
        Neurology. 1997; 49: 999-1003
        • Arnulf I.
        • Merino-Andreu M.
        • Bloch F.
        • et al.
        REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy.
        Sleep. 2005; 28: 349-354
        • Hansotia P.
        • Wall R.
        • Berendes J.
        Sleep disturbances and severity of Huntington's disease.
        Neurology. 1985; 35: 1672-1674
        • Wiegand M.
        • Moller A.A.
        • Lauer C.J.
        • et al.
        Nocturnal sleep in Huntington's disease.
        J Neurol. 1991; 238: 203-208
        • Garcia-Touchard A.
        • Somers V.K.
        • Olson L.J.
        • et al.
        Central sleep apnea: implications for congestive heart failure.
        Chest. 2008; 133: 1495-1504
        • McAinsh J.
        • Cruickshank J.M.
        Beta-blockers and central nervous system side effects.
        Pharmacol Ther. 1990; 46: 163-197
        • Miyazaki S.
        • Uchida S.
        • Mukai J.
        • et al.
        Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion.
        Psychiatry Clin Neurosci. 2004; 58: 138-144
        • Gentili A.
        • Godschalk M.F.
        • Gheorghiu D.
        • et al.
        Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial.
        Eur J Clin Pharmacol. 1996; 50: 463-465
        • Nicholson A.N.
        • Pascoe P.A.
        Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan.
        Neuropharmacology. 1991; 30: 367-372
        • Autret A.
        • Minz M.
        • Beillevaire T.
        • et al.
        Effect of clonidine on sleep patterns in man.
        Eur J Clin Pharmacol. 1977; 12: 319-322
        • Taylor F.B.
        • Martin P.
        • Thompson C.
        • et al.
        Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.
        Biol Psychiatry. 2008; 63: 629-632
        • Dietrich B.
        • Herrmann W.M.
        Influence of cilazapril on memory functions and sleep behaviour in comparison with metoprolol and placebo in healthy subjects.
        Br J Clin Pharmacol. 1989; 27: 249S-261S
        • Peter J.H.
        • Gassel W.
        • Mayer J.
        • et al.
        Effects of cilazapril on hypertension, sleep, and apnea.
        Am J Med. 1989; 87: 72S-78S
        • Kostis J.B.
        • Rosen R.C.
        • Wilson A.C.
        Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.
        J Clin Pharmacol. 1994; 34: 989-996
        • Eckernas S.A.
        • Roos B.E.
        • Kvidal P.
        • et al.
        The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
        Br J Clin Pharmacol. 1993; 35: 284-289
        • Parker K.P.
        • Bliwise D.L.
        • Bailey J.L.
        • et al.
        Polysomnographic measures of nocturnal sleep in patients on chronic, intermittent daytime haemodialysis vs those with chronic kidney disease.
        Nephrol Dial Transplant. 2005; 20: 1422-1428
        • Wetter T.C.
        • Stiasny K.
        • Kohnen R.
        • et al.
        Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome.
        Mov Disord. 1998; 13: 820-824
        • Benz R.L.
        • Pressman M.R.
        • Hovick E.T.
        • et al.
        Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders.
        Am J Kidney Dis. 2000; 35: 1052-1060
        • Perl J.
        • Unruh M.L.
        • Chan C.T.
        Sleep disorders in end-stage renal disease: “markers of inadequate dialysis”?.
        Kidney Int. 2006; 70: 1687-1693
        • Beecroft J.M.
        • Zaltzman J.
        • Prasad G.V.
        • et al.
        Improvement of periodic limb movements following kidney transplantation.
        Nephron Clin Pract. 2008; 109: c133-c139
        • Kraus M.A.
        • Hamburger R.J.
        Sleep apnea in renal failure.
        Adv Perit Dial. 1997; 13: 88-92
        • Hanly P.J.
        • Pierratos A.
        Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis.
        N Engl J Med. 2001; 344: 102-107
        • Dickman R.
        • Green C.
        • Fass S.S.
        • et al.
        Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease.
        J Clin Sleep Med. 2007; 3: 505-513
        • Idzikowski C.
        • Shapiro C.M.
        ABC of sleep disorders. non-psychotropic drugs and sleep.
        BMJ. 1993; 306: 1118-1121
        • Qureshi A.
        • Lee-Chiong Jr., T.
        Medications and their effects on sleep.
        Med Clin North Am. 2004; 88 (x): 751-766
        • Rotem A.Y.
        • Sperber A.D.
        • Krugliak P.
        • et al.
        Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome.
        Sleep. 2003; 26: 747-752
        • Keefer L.
        • Stepanski E.J.
        • Ranjbaran Z.
        • et al.
        An initial report of sleep disturbance in inactive inflammatory bowel disease.
        J Clin Sleep Med. 2006; 2: 409-416
        • Hirsch M.
        • Carlander B.
        • Verge M.
        • et al.
        Objective and subjective sleep disturbances in patients with rheumatoid arthritis. A reappraisal.
        Arthritis Rheum. 1994; 37: 41-49
        • Drewes A.M.
        • Svendsen L.
        • Taagholt S.J.
        • et al.
        Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions.
        Br J Rheumatol. 1998; 37: 71-81
        • Valencia-Flores M.
        • Resendiz M.
        • Castano V.A.
        • et al.
        Objective and subjective sleep disturbances in patients with systemic lupus erythematosus.
        Arthritis Rheum. 1999; 42: 2189-2193
        • Iaboni A.
        • Ibanez D.
        • Gladman D.D.
        • et al.
        Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression.
        J Rheumatol. 2006; 33: 2453-2457
        • Gudbjornsson B.
        • Broman J.E.
        • Hetta J.
        • et al.
        Sleep disturbances in patients with primary Sjogren's syndrome.
        Br J Rheumatol. 1993; 32: 1072-1076
        • Harding S.M.
        Sleep in fibromyalgia patients: subjective and objective findings.
        Am J Med Sci. 1998; 315: 367-376
        • Roizenblatt S.
        • Moldofsky H.
        • Benedito-Silva A.A.
        • et al.
        Alpha sleep characteristics in fibromyalgia.
        Arthritis Rheum. 2001; 44: 222-230
        • Born J.
        • Zwick A.
        • Roth G.
        • et al.
        Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans.
        Acta Endocrinol (Copenh). 1987; 116: 129-137
        • Obermeyer W.H.
        • Benca R.M.
        Effects of drugs on sleep.
        Neurol Clin. 1996; 14: 827-840
        • Murphy P.J.
        • Badia P.
        • Myers B.L.
        • et al.
        Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans.
        Physiol Behav. 1994; 55: 1063-1066
        • Gengo F.
        Effects of ibuprofen on sleep quality as measured using polysomnography and subjective measures in healthy adults.
        Clin Ther. 2006; 28: 1820-1826
        • Horne J.A.
        • Percival J.E.
        • Traynor J.R.
        Aspirin and human sleep.
        Electroencephalogr Clin Neurophysiol. 1980; 49: 409-413
        • Wang D.
        • Teichtahl H.
        Opioids, sleep architecture and sleep-disordered breathing.
        Sleep Med Rev. 2007; 11: 35-46
        • Eckert D.J.
        • Jordan A.S.
        • Merchia P.
        • et al.
        Central sleep apnea: pathophysiology and treatment.
        Chest. 2007; 131: 595-607